查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1597763

超級崩散劑市場：按類型、配方、治療領域分類 - 2025-2030 年全球預測

Superdisintegrants Market by Type (Natural Superdisintegrants, Synthetic Superdisintegrants), Formulation (Mouth-Dissolving Films, Tablets & Capsules), Therapeutic Area - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年超級崩散劑市值為5.6793億美元，預計到2024年將達到6.2944億美元，複合年成長率為10.92%，到2030年將達到11.7348億美元。

超級崩散劑是製藥工業的重要組成部分，主要用於錠劑和膠囊劑的配製，在與生物體液接觸時迅速崩壞，從而保證藥物的快速釋放和吸收。這種需求源於對高效藥物傳輸系統不斷成長的需求，其應用涵蓋各種類型的口服固態。最終用途範圍主要包括需要有效的即時釋錠劑和膠囊崩壞解決方案的製藥商。該市場的促進因素包括人口老化需要速效治療、製藥技術的進步以及向嚴重依賴高效製造製程的學名藥的轉變。此外，藥物配方的創新繼續推動對更好配方的需求，為公司提供開發性能、生物相容性和成本效益更高的新型化合物的機會。醫療基礎設施不斷擴大的新興市場具有巨大的成長潛力。然而，嚴格的監管要求以及創新和品管的高成本可能會阻礙快速的市場進入和成長。生物聚合物等新來源的研究和開發可以帶來突破，最大限度地降低生產成本並解決安全問題。此外，對個人化醫療和以患者為中心的藥物輸送系統的關注可能會刺激超級崩散劑的創新，以滿足特定患者的需求，例如客製化的藥物釋放曲線。市場競爭格局的特徵是不斷創新和產品差異化，這需要著重研發和策略聯盟。鼓勵公司投資先進製造技術和永續實踐，以保持領先地位。最後，有效應對監管環境可以縮短新崩壞製劑的上市時間並提高市場地位。

主要市場統計
基準年[2023] 56793萬美元
預測年份 [2024] 6.2944億美元
預測年份 [2030] 117,348 萬美元
複合年成長率（%） 10.92%

市場動態：揭示快速發展的超級崩散劑市場的關鍵市場洞察

供應和需求的動態相互作用正在改變超級崩散劑市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 口溶錠和膠囊的消耗量增加
    • 學名藥的採用增加
  • 市場限制因素
    • 對產品安全和品質的擔憂
  • 市場機會
    • 製藥業新型超級崩散劑的開發
    • 接受天然超級崩散劑
  • 市場問題
    • 製造超級崩散劑的高成本

波特的五力：駕馭超級崩散劑市場的策略工具

波特的五力框架是了解超級崩散劑市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解超級崩散劑市場的外部影響

外部宏觀環境因素在塑造超級崩散劑市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解超級崩散劑市場的競爭狀況

對超級崩散劑市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：超級崩散劑市場供應商績效評估

FPNV定位矩陣是評估超級崩散劑市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製超級崩散劑市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對超級崩散劑市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 口溶錠和膠囊的消耗量增加
      • 學名藥的採用增加
    • 抑制因素
      • 對產品安全和品質的擔憂
    • 機會
      • 醫藥產業新型超級崩散劑的開發
      • 接受天然超級崩散劑
    • 任務
      • 製造超級崩散劑的高成本
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章超級崩散劑市場：依類型

  • 介紹
  • 天然超級崩散劑
    • 膠
    • 黏液
    • 車前子黏液
  • 合成超級崩散劑
    • 矽酸鈣
    • 交聚維酮
    • 離子交換樹脂
    • 改性纖維素
      • 交聯羧甲基纖維素鈉
      • 低取代羥丙基纖維素
    • 改質澱粉

第7章超級崩散劑市場：按配方

  • 介紹
  • 口腔溶解膜
  • 錠劑和膠囊

第8章超級崩散劑市場：依治療領域

  • 介紹
  • 心血管疾病
  • 消化系統疾病
  • 血液疾病
  • 感染疾病
  • 發炎疾病
  • 神經系統疾病
  • 腫瘤學

第9章 北美、南美超級崩散劑市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太超級崩散劑市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲超級崩散劑市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Anshul Life Sciences
  • Asahi Kasei Corporation
  • Ashland Global Specialty Chemicals Inc.
  • Avantor Performance Materials, LLC
  • BASF SE
  • DFE Pharma GmbH & Co KG
  • DowDuPont Inc.
  • FMC Corporation
  • Gangwal Chemicals Pvt. Ltd.
  • Huber Corporation
  • JRS PHARMA GmbH+Co. KG
  • Nippon Soda Co., Ltd.
  • NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
  • Roquette Freres SA
  • Sigachi Industries Pvt Ltd.
Product Code: MRR-4103B31E087F

The Superdisintegrants Market was valued at USD 567.93 million in 2023, expected to reach USD 629.44 million in 2024, and is projected to grow at a CAGR of 10.92%, to USD 1,173.48 million by 2030.

Superdisintegrants are critical components in the pharmaceutical industry, primarily used in the formulation of tablets and capsules to facilitate their rapid disintegration upon contact with biological fluids, hence ensuring quick drug release and absorption. Their necessity arises from the growing demand for efficient drug delivery systems, and their applications span across various types of oral solid dosage forms. The end-use scope primarily includes pharmaceutical manufacturers who require effective disintegration solutions for immediate-release tablets and capsules. The market is driven by factors such as an increasing aging population needing rapid-acting therapeutics, advances in pharmaceutical technologies, and the shift towards generic drugs which rely heavily on efficient production processes. Furthermore, innovations in drug formulation continue to propel the need for better superdisintegrants, presenting opportunities for companies to develop novel compounds offering improved performance, biocompatibility, and cost-effectiveness. Emerging markets with expanding healthcare infrastructure provide considerable potential for growth. However, limitations exist due to stringent regulatory requirements and high costs of innovation and quality control, which can hinder quick market access and thus growth. Research and development into new sources of superdisintegrants, such as biopolymers, could provide breakthroughs, minimizing production costs and addressing safety concerns. Moreover, a focus on personalized medicine and patient-centric drug delivery systems could spur innovations in superdisintegrants that align with specific patient needs, such as tailored drug release profiles. The market's competitive landscape is characterized by constant innovation and product differentiation, thereby necessitating a strong emphasis on R&D and strategic collaborations. Companies are recommended to invest in advanced manufacturing technologies and sustainable practices to stay ahead. Lastly, navigating the regulatory landscape efficiently can also create opportunities by accelerating time-to-market for new superdisintegrant formulations, thus enhancing their market position.

KEY MARKET STATISTICS
Base Year [2023] USD 567.93 million
Estimated Year [2024] USD 629.44 million
Forecast Year [2030] USD 1,173.48 million
CAGR (%) 10.92%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Superdisintegrants Market

The Superdisintegrants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing consumption of orally disintegrating tablets and capsules
    • Rising adoption of the generic drugs
  • Market Restraints
    • Concerns related to the safety and quality of product
  • Market Opportunities
    • Development of new superdisintegrants for the pharmaceutical industry
    • Acceptance of natural superdisintegrants
  • Market Challenges
    • High-cost associated with manufacturing of superdisintegrants

Porter's Five Forces: A Strategic Tool for Navigating the Superdisintegrants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Superdisintegrants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Superdisintegrants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Superdisintegrants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Superdisintegrants Market

A detailed market share analysis in the Superdisintegrants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Superdisintegrants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Superdisintegrants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Superdisintegrants Market

A strategic analysis of the Superdisintegrants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Superdisintegrants Market, highlighting leading vendors and their innovative profiles. These include Anshul Life Sciences, Asahi Kasei Corporation, Ashland Global Specialty Chemicals Inc., Avantor Performance Materials, LLC, BASF SE, DFE Pharma GmbH & Co KG, DowDuPont Inc., FMC Corporation, Gangwal Chemicals Pvt. Ltd., Huber Corporation, JRS PHARMA GmbH + Co. KG, Nippon Soda Co., Ltd., NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD., Roquette Freres S.A., and Sigachi Industries Pvt Ltd..

Market Segmentation & Coverage

This research report categorizes the Superdisintegrants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Natural Superdisintegrants and Synthetic Superdisintegrants. The Natural Superdisintegrants is further studied across Gums, Mucilage, and Plantago Ovata Mucilage. The Synthetic Superdisintegrants is further studied across Calcium Silicates, Crospovidone, Ion Exchange Resins, Modified Cellulose, and Modified Starch. The Modified Cellulose is further studied across Croscarmellose Sodium and Low-Substituted Hydroxypropyl Cellulose.
  • Based on Formulation, market is studied across Mouth-Dissolving Films and Tablets & Capsules.
  • Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Gastrointestinal Diseases, Hematological Diseases, Infectious Diseases, Inflammatory Diseases, Neurological Diseases, and Oncology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing consumption of orally disintegrating tablets and capsules
      • 5.1.1.2. Rising adoption of the generic drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to the safety and quality of product
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of new superdisintegrants for the pharmaceutical industry
      • 5.1.3.2. Acceptance of natural superdisintegrants
    • 5.1.4. Challenges
      • 5.1.4.1. High-cost associated with manufacturing of superdisintegrants
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Superdisintegrants Market, by Type

  • 6.1. Introduction
  • 6.2. Natural Superdisintegrants
    • 6.2.1. Gums
    • 6.2.2. Mucilage
    • 6.2.3. Plantago Ovata Mucilage
  • 6.3. Synthetic Superdisintegrants
    • 6.3.1. Calcium Silicates
    • 6.3.2. Crospovidone
    • 6.3.3. Ion Exchange Resins
    • 6.3.4. Modified Cellulose
      • 6.3.4.1. Croscarmellose Sodium
      • 6.3.4.2. Low-Substituted Hydroxypropyl Cellulose
    • 6.3.5. Modified Starch

7. Superdisintegrants Market, by Formulation

  • 7.1. Introduction
  • 7.2. Mouth-Dissolving Films
  • 7.3. Tablets & Capsules

8. Superdisintegrants Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Cardiovascular Diseases
  • 8.3. Gastrointestinal Diseases
  • 8.4. Hematological Diseases
  • 8.5. Infectious Diseases
  • 8.6. Inflammatory Diseases
  • 8.7. Neurological Diseases
  • 8.8. Oncology

9. Americas Superdisintegrants Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Superdisintegrants Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Superdisintegrants Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anshul Life Sciences
  • 2. Asahi Kasei Corporation
  • 3. Ashland Global Specialty Chemicals Inc.
  • 4. Avantor Performance Materials, LLC
  • 5. BASF SE
  • 6. DFE Pharma GmbH & Co KG
  • 7. DowDuPont Inc.
  • 8. FMC Corporation
  • 9. Gangwal Chemicals Pvt. Ltd.
  • 10. Huber Corporation
  • 11. JRS PHARMA GmbH + Co. KG
  • 12. Nippon Soda Co., Ltd.
  • 13. NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
  • 14. Roquette Freres S.A.
  • 15. Sigachi Industries Pvt Ltd.

LIST OF FIGURES

  • FIGURE 1. SUPERDISINTEGRANTS MARKET RESEARCH PROCESS
  • FIGURE 2. SUPERDISINTEGRANTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SUPERDISINTEGRANTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SUPERDISINTEGRANTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SUPERDISINTEGRANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SUPERDISINTEGRANTS MARKET DYNAMICS
  • TABLE 7. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY GUMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MUCILAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY PLANTAGO OVATA MUCILAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CALCIUM SILICATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CROSPOVIDONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY ION EXCHANGE RESINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CROSCARMELLOSE SODIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED STARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MOUTH-DISSOLVING FILMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY HEMATOLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 284. SUPERDISINTEGRANTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 285. SUPERDISINTEGRANTS MARKET, FPNV POSITIONING MATRIX, 2023